Background: This report documents the outcomes of cardiac surgical mission trips organized by the International Children's Heart Foundation (ICHF), a nongovernmental organization that provides congenital heart surgery services to the developing world, and discusses factors associated with a reduction of mortality and morbidity in this setting. Methods: A retrospective review of a prospectively maintained database was conducted to identify any patient who underwent surgical intervention during the course of an ICHF mission trip. Results: From 2008 to 2016, a total of 223 trips were made to 23 countries and 3,783 operations were performed. Over 40 unique types of operations were performed with repairs of atrial septal defects (ASDs; n ¼ 479), ventricular septal defects (VSDs; n ¼ 760), teratology of Fallot (n ¼ 473), and ligation of patient ductus arteriosus (PDA; n ¼ 242), comprising the majority of cases. Several organizational policy changes were instituted in 2015. These include the requirement of the host site to have a fully functional blood bank and access to medical subspecialties, the ICHF providing 24-hour intensivist coverage, and not performing surgery on patients weighing less than 10 kg until local capacity has been developed. The overall mortality rate fell to 2.3% from 8.1% after the implementation of these policies. The mortality for ASD repair, VSD repair, PDA ligation, and the repair of tetralogy of Fallot fell from 1.2% to 0%, 1.8% to 0%, 0% to 0%, and 5.6% to 5.1%, respectively. The reoperation rate fell from 11% to 3% and reoperation for a bleeding indication fell from 6% to 2%. Conclusions: Programmaticlevel changes have been associated with reduced rates of mortality and morbidity in humanitarian congenital cardiac surgery.
Introduction
It is estimated that up to 1 in 100 children will be born with a congenital cardiac defect, and this incidence may be even higher in developing nations where the capacity to care for the patients is low or completely absent. 1, 2 In this regard, cardiothoracic surgeons have a long and storied history of humanitarian aid, and this is particularly true within the specialty of congenital heart surgery. [2] [3] [4] [5] [6] [7] There are numerous reports within the literature that document the process and challenges of providing humanitarian surgical care to those who have cardiac disease; however, there are few reports detailing the clinical outcomes of these patients and the efforts that have been made to improve their clinical outcomes.
This report aims to document the experience and outcomes of the International Children's Heart Foundation (ICHF), a nongovernmental organization that provides congenital heart surgery services to the developing world as well as analyze and discuss programmatic-level changes that reduced mortality and morbidity in this arena. In existence since 1993, ICHF, based in Memphis, Tennessee, provides surgical care by assembling volunteer medical teams that provide preoperative, operative, and postoperative care during the course of twoweek mission trips. collection, in accordance with each institution's standard practices. The use of data for research purposes is reviewed by ICHF's board of directors and, if data are released, it is deidentified. Institution review board approval for this study was also granted by Mercy Catholic Medical Center, the first author's institution.
Abbreviations and Acronyms
A retrospective review of a prospectively maintained database was conducted to identify any patient who underwent surgical intervention during the course of an ICHF mission trip. From 2008 to 2016, a total of 223 trips to 25 countries were performed, and 3,783 cases were identified for analysis ( Figure 1) .
The ICHF humanitarian surgical team is coordinated by its US office in conjunction with the site's local health ministry and/or administration. Screening visits occur before the surgical team visit to evaluate prospective patients, referred by local physicians and cardiologists, for surgical selection. If a patient is deemed an operative candidate, the ICHF cardiologist screens the patient upon the team's arrival in country. This evaluation includes an echocardiogram and cardiac catheterization, when indicated. The patient is then presented during a multidisciplinary conference and a final decision on the patient's candidacy for surgery is made. Of note, both the screening and the ICHF cardiologist assist with the interpretation of postprocedure epicardial echocardiography or transesophageal echocardiogram (TEE), where available as well as predischarge TTE.
The ICHF team seeks to complete as many successful operations as clinically possible within a two-week time. The multidisciplinary team includes 15 to 30 volunteers, including licensed medical doctors, nurses, allied health professionals, biomedical personnel, and paramedical personnel and additional staff to manage logistical concerns. All teams included cardiac surgeon, cardiac anesthesiologist, operating room, and intensive care nurses as well as biomedical personnel. Depending upon the local institution's capacity, the team may have also included a cardiologist, an interventional cardiologist, an intensivist, a respiratory therapist, and a perfusionist. Each mission was comprised of a unique team; however, the Foundation frequently utilizes repeat volunteers to serve the same site on multiple trips.
The ICHF team collaborates with local medical and nursing staff on all aspects of patient care. Education and training are aimed at eventual in situ capability. Funds to cover the costs of trip are completely met by donations from individual volunteers, medical companies, and grants.
In 2015, there was a change in both administrative and physician leadership. During the course of this transition, an internal review of the organization's outcomes was performed. The medical staff participating in this review has been affiliated with the organization for over 10 years and were able to provide valuable information as to where weakness existed within the organization. While the reviewed outcomes were deemed acceptable, taking into account that most sites lacked advanced technologies such as extracorporeal membrane oxygenation (ECMO), ventricular assist devices, and inhaled nitric oxide, they were notably higher than similarly reported outcomes in industrialized nations. At this time, a series of programmatic-level policy changes were made in order to improve outcomes and reduce mortality and morbidity.
These changes included a policy that the organization would only perform interventions at centers with a fully functional blood bank that provided access to blood products. Further, the organization would work with sites without this capability in order to establish it. The organization also restructured its team composition so that 24-hour a day, in-house, intensivist coverage was provided by a volunteer intensivist. Additionally, ICHF required sites to provide access to practitioners who had advanced training in medical subspecialties, such as pediatric pulmonology and pediatric nephrology, in order to provide more comprehensive postoperative care.
Several policy changes were also made in the preoperative phase of patient evaluation. Among these were the policy that the organization would not consider any patient who weighed less than 10 kg until the local capacity was well established. From 2008 to 2014, the mortality rate for patients less than 10 kg was 8.1% (n ¼ 115 of 1,414 patients), which is similar to the overall mortality rate. However, it was the belief of the organization's practitioners that these patients were at the greatest risk of complications.
Further, the preoperative assessment of patients just prior to surgery was also modified to resemble protocols in the developed world.
Unfortunately, working within the constraints of a database that was originally designed for administrative purposes, it was not possible to determine exactly how many sites lacked medical subspecialties, a fully functional blood bank, or precisely a 24-hour intensive care coverage. However, given that leadership of the organization had significant experience working within this system, these policy changes were well agreed upon as to having the greatest potential to reduce mortality and morbidity.
In order to assess the potential impact of these policy changes on patient outcomes, we stratified analysis of outcomes on the basis of two epochs: prior to their implementation (2008 to 2014), and after implementation (2015 to 2016).
Statistical analysis was completed using SPSS software (IBM, Inc, Armonk, New York). Continuous variables are expressed as mean + standard deviation. Categorical variables are expressed as percentage and were analyzed using w 2 test or the Fisher exact test when appropriate.
Results
Preoperative characteristics for the total cohort are summarized in Table 1 . The average patient age was 5 years with a range from 4 days to 60.6 years. Fifty-one percent was male with 20% presenting with some degree of malnourishment, with 4% being emaciated. Nutritional status was determined by clinical evaluation of a multidisciplinary team. Twentyseven percent required preoperative intensive care unit (ICU) care and 11% required reoperation. Most patients requiring preoperative ICU care required hydration with close fluid balance monitoring. Over 40 unique types of operations were performed with repairs of atrial septal defects (ASDs; n ¼ 479), ventricular septal defects (VSDs; n ¼ 828), tetralogy of Fallot (n ¼ 473), and ligation of patent ductus arteriosus (PDA; n ¼ 242), comprising 1,602 total cases or 53.4% of the total cohort (Table 2) .
Intraoperative outcomes for the total cohort are summarized in Table 3 . The average cardiopulmonary bypass time was 100 + 74 minutes with an average cross clamp time of 54 + 39 minutes. Intraoperative blood product utilization occurred in 1,013 patients or 27%.
Overall, in-hospital mortality was 8.1%. The reoperation rate was 11.1%, of which 5.7% of the total cohort returned to the operating room for a bleeding indication. Further, operative revision of the index procedure (ie, rerepair of the previously repaired VSD) occurred at a rate of 2.6%. Reoperation was defined as a return to the operating room during the same admission. Permanent pacemaker insertion rate was 0.5% (Table 4) .
Analysis of the most commonly performed operations revealed the following rates of mortality: repair of tetralogy of Fallot 5.6%, repair of an ASD 1.2%, repair of a VSD 1.8%, and ligation of PDA 0% (Table 5) .
When considering the organization's early (2008-2014) versus late (2015-2016) patients, patients in the late group were more likely to be older, taller, and heavier. Further, patients in the latter half of the organization's experience were more likely to be malnourished as compared to the early experience but less likely to have progressed to an emaciated state. A comparison of the patient's presentation from 2008 to 2015 and 2015 to 2016 is summarized in Table 6 . Operative outcomes between the two groups were similar, with no significant difference in cardiopulmonary bypass times or cross clamp time. Intraoperative blood product utilization was significantly higher in the late portion of our experience, 56.8% when compared to 24.5% (Table 7 ).
An analysis of postoperative outcomes demonstrates a positive effect of the program's policy changes. The reoperation rate fell from 11.79% to 2.29% (P ¼ .0001), and the reoperation rate for a bleeding indication fell from 5.94% to 1.91% (P ¼ .0034). Further, the reintubation rate changed from 10% to 5.73% (P ¼ .022). Overall mortality dropped from 8.2% to 2.29% (P ¼ .0003). These results are summarized in Table 8 .
We also analyzed the contemporary outcomes for the most commonly performed procedures, as summarized in Table 9 . The mortality rate for ASD repair, VSD repair, and PDA ligation fell to 0% (P ¼ NS). The mortality rate for the repair of tetralogy of Fallot fell from 5.6% to 5.13% (P ¼ 1). 
Comment
The global burden of congenital heart disease cannot be overstated. It is estimated that each year approximately 1.35 million infants are born with congenital heart disease. This corresponds to 9.1 patients per 1,000 live births. 8 Rates in the developing world are likely even higher; however, accurate reporting from these areas is not available. The majority of children born with congenital heart disease in developing nations are less likely to receive the care they require, resulting in high morbidity and mortality. Several factors contribute to this reality. The vast majority of congenital heart centers are in industrialized nations. Further, the high cost associated with cardiac care is prohibitive for most of the developing world. Late clinical presentation, significant comorbidities including malnutrition, and lack of trained professionals are also frequently cited as sources of poor outcomes within this patient population. 9 Founded in 1993, the ICHF aims to combat these issues by providing quality surgical care through repeat mission trips. International teams of medical professionals are assembled for two-week trips to nations in need. A forward team or local medical staff identify potential candidates for surgery prior to the team's arrival, and, in turn, upon arrival the team reevaluated these patients, identifying the patients requiring surgery.
Over the course of a two-week trip, there are typically ten operative days with one to two cases per day. A smaller team of nurses and intensivists stay in the host country approximately 72 hours after the final case in order to ensure a smooth transition of care. If a patient remains hospitalized at the time of this team's departure, care is transferred to the local medical team which typically includes both a pediatrician and a cardiologist.
Education, with the focus on eventual autonomy on the programmatic level, is a cornerstone of the ICHF mission. This is accomplished via a one-to-one model which pairs a local practitioner, be it physician, nursing, or allied health, with a team member during the course trip. Education is further enhanced by multidisciplinary rounding and traditional didactics. Further, whenever possible, a volunteer surgeon returns multiple times to the same site. This concept of 1:1 pairing and long-standing relationships with the host site creates a longterm, international "twinning" association, as described by Dearani et al. 10, 11 The ultimate goal of any visiting practitioner is to provide a level of care to their patients in the developing world comparable to that of their home institution. This report presents the clinical outcomes of ICHF's mission from 2008 to 2016, which corresponds to the time frame for which reliable data are available, in an effort to establish the mortality and morbidity rates observed during the practice of humanitarian congenital heart surgery. Further, in order to improve morbidity and mortality, a discussion of programmatic changes is presented along with contemporary outcomes.
Over the eight-year study period, there were 3,783 cases in 25 different countries. An analysis of the case mix, as demonstrated in Table 2 , illustrates both the complexity and the diversity of pathology encountered by the organization. Over 40 unique procedures were performed, and approximately half of the total caseload involved repair of ASD, VSD, tetralogy of Fallot, or ligation of PDA, which mirrors most centers within North America and Western Europe.
The Risk Adjusted Classification for Congenital Heart Surgery (RACHS-1) was initially published in January 2002. 12 In their work analyzing mortality when compared to RACHS-1 scores, Jacobs et al studied 45,635 cases that had been submitted to the Society for Thoracic Surgery (STS) national database and stratified these cases' mortality by RACHS-1 score. They found that a RACHS-1 score of 1 corresponded to a mortality rate of 0.6%, a RACHS-1 score of 2 corresponded to a mortality rate of 1.4%, a RACHS-1 score of 3 corresponded to a mortality rate of 4.1%, a RACHS-1 score of 4 corresponded to a mortality rate of 8.7%, and a RACHS-1 score of 5 or 6 corresponded to a mortality rate of 20.2%. 13 The PDA ligation is classified as a RACHS-1 score of 1, and in our series we did not observe any mortality with these operation, which is similar to reported rate of 0.6%. The ASD repair, VSD repair, and tetralogy of Fallot repair are all classified as a RACHS-1 score of 2. In our report, the mortality rate of ASD repair was 1.2%, and for VSD repair, it was 1.8% which is similar to the reported RACHS-1 category 2 rate. Mortality for repair of tetralogy of Fallot in our series was 5.6%, which is notably higher than the expected RACHS-1 category 2 rate of 1.4%. Although the outcomes of ASD and VSD repair as well as PDA ligation align well with the expected mortality as predicted by RACHS-1 score, the overall mortality, 8.1%, along with the mortality observed for the repair of tetralogy of Fallot, 5.6%, are notably higher than those reported by Jacobs et al in their review of the STS database.
14 Obviously, working within resource scare nations comes with significant challenges. Notably, modalities including ECMO, ventricular assist devices, and inhaled nitric oxide were not available during the course of this study. While it is difficult to quantify the number of patients who would have benefited from these technologies, there is little doubt that had they been available the overall mortality rate would have been decreased.
The observed reoperation rate up to 2014 was 11.79%, and the reoperation rate for a bleeding indication was 5.94% or almost half of all reoperations. From 2008 to 2014, the organization had no established protocols regarding blood product availability or usage. Further, the organization worked at several institutions that did not possess a fully operational blood bank. In order to combat this issue, the organization instituted a policy that they would only perform interventions at centers that provided access to blood products with a fully functional blood bank. In addition, the institution would work with sites without this capability in order to establish it.
Prior to 2014, the volunteer team consisted of the aforementioned team members that included a single intensive care physician and, at times, an intensive care advanced practitioner. In order to address the observed reintubation rate as well as in an effort to reduce the overall morbidity, a policy was instituted that required 24-hour a day, in-house, intensivist coverage. Additionally, ICHF required sites to provide access to practitioners who had advanced training in medical subspecialties, such as pulmonology and nephrology, in order to provide more comprehensive postoperative care.
Several policy changes were also made in the preoperative phase of patient evaluation. Among these were the policy that the organization would not undertake any case where patients weighed under 10 kg until local capacity was well established. After each mission and prior to the next, a multidisciplinary team including members of ICHF and the host institution held a debriefing meeting. When both parties concluded that progress was ongoing and that the institution was operating at an acceptable level, then cases of children under 10 kg were considered. This was the result of not a single criterion but rather the product of ongoing process improvements and discussion between the foundation and the site. The mortality rate for patients under 10 kg during the later portion of the experience fell to 1.4% (n ¼ 1 of 71 patients), demonstrating the value of this policy.
Further, the preoperative assessment of patients just prior to surgery was also modified to resemble protocols in industrialized nations. For example, if a child presented for an elective surgery and had an active viral illness, their case was delayed until resolution of this condition. As one can imagine, it is tempting to push the boundaries of who is acceptable for the operating room as a delay in a case means a wait time of months for the patient, until the team returns for the next mission. It is possible that this pressure may have resulted in some cases being undertaken during the earlier era that would likely have been delayed under such circumstances in a resource-rich nation. Since 2014, we have adhered to new policies in an effort to minimize morbidity.
In order to analyze the impact of these policy changes on patient outcomes, we divided the cohort into the time period prior to their institution, from 2008 to 2014, after, and from 2015 to 2016.
Operative outcomes between the 2 groups were similar, with no significant difference in cardiopulmonary bypass times or cross clamp time. Intraoperative blood product utilization was significantly higher in the latter part of our experience, 56.8% when compared to 24.5% (Table 7) . This is likely due to the increased access to blood products because from 2015 to 2016 surgeries were done only at sites that had a functional blood bank.
An analysis of postoperative outcomes demonstrates a positive effect of the program's policy changes. The reoperation rate fell from 11.79% to 2.29% (P ¼ .0001) and the reoperation rate for a bleeding indication fell from 5.94% to 1.91% (P ¼ .0034). Further, the reintubation rate changed from 10% to 5.73% (P ¼ .022). Overall mortality dropped from 8.2% to 2.29% (P ¼ .0003). These results are summarized in Table 8 . Taken in totality, the significant drop in mortality and morbidity noted in the latter portion of the organization's experience demonstrates the positive impact that the aforementioned policy changes have had.
We also analyzed the contemporary outcomes for the most commonly performed procedures as summarized in Table 9 . The mortality rate for ASD repair, VSD repair, and PDA ligation fell to 0%. These results did not reach statistical significance, likely secondary to the small sample size. The mortality rate for the repair of tetralogy of Fallot fell from 5.6% to 5.13% (P ¼ 1). The observed rates for ASD repair, VSD repair, and PDA ligation are similar to those reported in North America, as reported by Jacobs et al in their review of the STS database.
14 The repair of tetralogy of Fallot remains a challenge in the humanitarian sphere. We believe that although a mortality of 5.13% is significantly higher than that reported by the STS, it is not significantly higher than the rate reported by other developing nations. 15, 16 It should be noted that, unlike patients undergoing repair of ASDs or VSDs, these patients tend to be significantly more cyanotic with very high hemoglobin levels, and this may predispose the patients toward both preexisting coagulopathies and neurologic injuries. Ongoing research is needed to better delineate what factors are driving the observed rate and what policies may aid in reducing it.
Limitations
Our study is limited in several respects. This is a retrospective review of a prospectively collected database, and thus all clinically relevant end points could not be evaluated. While the mortality for the most commonly performed procedures is consistent with the rates published in the literature, the overall mortality rate is notably higher for these cases. There are far more patients in need of intervention than any humanitarian organization can provide care for, thus, a selection bias may exist. Therefore, ongoing research is needed to better delineate the screening and selection process that patients undergo in the humanitarian setting. Furthermore, it is important to identify which less commonly performed operations are associated with significant mortality as well as predictors of that mortality.
Conclusions
The vast majority of the world's children who require cardiac surgery do not have access to it. Humanitarian organizations, such as ICHF, aim to bridge that gap through both surgical missions and education and training. By initiating several program-level changes, the organization has been able to significantly reduce its morbidity and mortality and help its host sites work toward the development of their own programs.
